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While the presence of immunoglobulin receptor molecules on immunocompe- 
tent cells had been detected by a variety of procedures (1), much remains to be 
learned as to the dynamics of their synthesis and function. The adjuvant action 
on  the  immune  response  of  complexed  synthetic  polynucleotides  has  been 
described (2) and characterized (3). The cellular targets for this adjuvant seem 
to  include  the  three  cell  populations  implicated  in  humoral  immunity:  the 
macrophage  (4),  the  thymus-influenced  cell  (5,  6),  and  the  bone-marrow  de- 
rived cell  (7).  Recently,  it was reported  that  complexes of polyadenylic aci:l- 
polyuridylic  acid  (poly  A:U)  1 could  inhibit  both  rosette  formation  and  the 
immune  responsiveness  of primed  spleen  cells,  presumably  by depressing  the 
antigen-binding  capacity  of  the  cells  (8).  The  present  report  confirms  the 
hypothesis that poly A: U  depresses  the antigen-binding capacity of lymphoid 
cell  populations  and  demonstrates  that  the  depression  of  antigen-binding  is 
associated  with  polynucleotide-mediated  stimulation  of cell  metabolism  and 
release of membrane proteins,  resulting in a  loss of membrane-bound receptors 
for antigen. 
Materials and Methods 
Immunizations.--fl-Galactosidase  (~GZ) was  obtained  from  Worthington  Biochemicals, 
Freehold, N.J. 6-wk old female Balb/c mice (Charles River Breeding Laboratories, Wilming- 
ton, Mass.) were inoculated intraperitoneally  with  50 #g/~GZ in Freund's  incomplete adju- 
vant. Studies were initiated  6-10 wk later. 
Cortisone Treatment.--6  wk after  priming with/3GZ,  the mice received 5.0 mg cortisone 
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1 Abbreviations used in  this  paper: •GZ,  fl-galactosidase;  BSA, bovine  serum  albumin; 
cAMP, 3  I, 5'-cyclic monophosphoric acid; FCS, fetal calf serum; FD~G, fluorescein di-/J-galac- 
torpyranoside;  FITC-RAMIg,  fluorescein  conjugated  rabbit  antimouse  immunoglobulin 
serum;  HBSS,  Hanks'  balanced  salt  solution;  MEM,  minimum  essential medium;  PBS, 
phosphate-bufered  saline; poly  A,  polyadenyllc  acid;  poly A:U,  polyadeny]ic  acid-poly- 
uridylic acid; poly U, polyuridylic acid; TCA, trichIoroacetic acid. 
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(Cortone; Merck, Sharp, and Dohme, Philadelphia, Pa.)  intraperitoneally. Spleens were re- 
moved for experimentation 72 h after the cortisone injection. 
Antimetabolites.--Puromycin  dihydrochloride (Nutritional Biochemicals Corp., Cleveland, 
Ohio)  was suspended in 0.15 M  NaC1 to 1 raM. Iodoacetic acid (Mann Research Labs, Inc., 
New York)  was suspended to 1 M  in 0.15  M  NaC1 and the pH adjusted to 7.0 with 0.5 N 
NaOH. Sodium azide (Alfa Inorganics, Inc., Beverly, Mass.) was suspended to 10 M in 0.15 M 
NaC1. All antimetabolites were diluted to desired concentration in tissue culture medium. 
Homoribopolynueleotides.--Polyadenylic  acid  (poly A),  potassium salt  (lot  no.  73),  and 
polyuridylic acid (poly U), ammonium salt (lot no. 81), were obtained from Miles Laboratories 
Inc., Miles Research Div., Kankakee, Ill. Each polymer was stored at  --20°C at a concen- 
tration of 4 mg/ml in sterile 0.15 M phosphate-bufered  saline (PBS), pH 7.2 (0.073 M NaC1, 
0.018 M KH2PO4,0.057 M Na2HPO4).  Polymers were complexed before use by mixing equal 
volumes of the two stock solutions for 2 rain at room temperature. The polymer complex was 
diluted to desired concentration in tissue culture medium. 
Dibutyryl adenosine-3',  5'-cyclic  monophosphoric acid (cAMP) and theophylline were ob- 
tained from Sigma Chemical Corp., St. Louis, Mo. They were suspended in sterile 0.15  M 
NaC1 and diluted to desired concentration in tissue culture medium. 
Cell Suspensions.--Mice were killed  by cervical dislocation. The spleens or thymuses were 
removed and dispersed in cold Hanks' balanced salt solution (HBSS, Microbiological Associ- 
ates, Inc., Bethesda, Md.) using a  loose-fitting Ten-Broeck tissue homogenizer (Fisher Sci- 
entific Co., Springfield,  N.J.). The cells were washed by centrifugation at 450 X  g three times 
in HBSS containing 5% fetal calf serum  (FCS,  Grand Island Biological Co., Grand Island, 
N.Y.). After the first wash, red blood cells were lysed by suspending the cells in a hypotonic 
solution composed of 0.830/o NH4C1 and 0.2% dextran, pH 7.0, for 8 rain at 0°C. Adherent cells 
were removed, when necessary, by incubating the cells at 37°C with glass wool for 15 min. The 
cells were resuspended to  1.5  )<  107 cells/ml in either HBSS or Eagle's minimum essential 
medium (MEM, Hyland Div., Travenol Laboratories, Inc., Costa Mesa, Calif.). 
Polynudeotide Treatment.--The cell suspensions  were warmed to 37°C. Poly A: U was added 
to the appropriate concentration and the suspension was incubated at 37°C for 10 rain. The 
cells were centrifuged to remove excess poly A:U, resuspended in warm HBSS containing 5% 
FCS, and incubated for an additional 30 min at 37°C. The cells were washed two times in cold 
HBSS +  5% FCS before exposure to antigen. The viability of the poly A:U-treated cells, as 
measured by Trypan blue dye exclusion,  was not significantly different than the viability of 
control cells, both of which were greater than 85%. 
Fluorescent Anti-Ig  Assay.--Fluoroscein  conjugated  rabbit  antimouse  immunoglobulin 
serum (FITC-RAMIg) was kindly provided by Dr. Emll Unanue (9). Spleen cells were sus- 
pended in HBSS to 5 )<  107 cells/ml. 10/zl of the FITC-RAMIg reagent was added to 100/zl 
of the cell suspension. The mixture was incubated 30  min at 0°C,  washed four times with 
HBSS +  5% FCS, and resuspended to 1 )<  107 cells/ml. Smears were fixed in methanol and 
scanned for fluoroscein  label. 
~-Galactosldase-Bindlng Assay.--Antigen  (/3GZ)binding  activity of cell suspensions was 
determined by a  method which is  based on the ability of flGZ to hydrolyze a  fluorogenic 
substrate  (10).  Briefly,  spleen cells  to  be assayed were suspended to  5  X  l0 T cells/ml in 
HBSS +  5% FCS./3GZ was added to a final concentration of 50 #g/ml. The suspensions were 
incubated at 0°C for 60 rain and then washed by centrifugation four times in HBSS. Replicate 
0.2 ml samples (containing approximately 3  X  106 cells) were dispensed to fluorometer tubes. 
An equal volume of 4  X  10  -5 M fluoroscein  di-/3-galactopyranoside (FD~G, Schwarz/Mann 
Div., Becton, Dickinson, and Co., Orangeburg, N.Y.), a fluorogenic  substrate for flGZ, was 
then added to the tubes. Controls for the determination of specific  activity of the enzyme 
(/3GZ) consisted of triplicate tubes containing 1 ng flGZ in 0.2 ml HBSS and 0.2 ml 4 X  10  -5 M 
FDflG. The assay tubes  were incubated  at 37°C for 10-90 min. At regular intervals (10-20 ROBERT  D.  STOUT  AND  ALBERT  H.  COONS  877 
min), the tubes were read in  a fluorometer and the rate of fluoroscein release (FD/~G break- 
down) determined. The amount of/~GZ bound to the cells was calculated as follows: 
pg/~GZ  bound/106  cells  - 
AFU/min 
NXS~ 
where AFU equals increase in fluorometer units, N  equals number of cells (X  10-6), and  S~ 
equals specific activity of/3GZ (AFU/min per pg). 
Radioiodination  of Membrane  Proteins.--The membrane proteins of spleen cells were radio- 
iodinated by the technique described by Marchalonis et al. (11). Carrier-free 125I (50 mCi/ml, 
Na125I  in 0.1  N  NaOH)  was  obtained from New  England Nuclear,  Boston,  Mass.  Lacto- 
peroxidase  (B-grade,  lyophilized) was  obtained from Calbiochem,  San Diego,  Calif.  Spleen 
cells were suspended in PBS, pH 7.2, to 1.5 X  107 cells/ml. The cells were dispensed in 10 ml 
aliquots to 50 ml plastic screw-capped centrifuge tubes. To each 10 ml aliquot of cells was 
added 0.4 ml lactoperoxidase (0.3  mg/ml), 0.05 ml 1~5I (diluted in PBS to 5 mCi/ml), and 
0.6 ml of 10 pM H202.  Mter incubation for 5 min at 30°C,  30 ml of cold PBS containing 
5 mM cysteine (L-cysteine HC1,  Nutritional Biochemicals Corp.)  was added. The cells were 
washed one time with PBS  +  5 mM cysteine, two times with HBSS,  and resuspended to 
1.5  X  107 cells/ml in HBSS.  Poly A:U was added to half the cells to a  final concentration 
of 100 ng/ml. Both poly A:U-treated and untreated (control) cells were incubated for 10 min 
at 37°C, centrifuged, resuspended to 1.5 X  107 cells/ml in Eagle's MEM, and returned to the 
37°C water bath. At regular intervals, 0.5 ml samples were removed. The cells were eliminated 
by centrifugation at 500  X  g and the supernatant was held at 0°C  until all samples were 
collected.  To  each sample was added  50 tzl of  10%  bovine serum  albumin  (BSA,  Armour 
Pharmaceutical Co., Chicago, Ill.)  and 0.5 ml cold 10% trichloroacetic acid  (TCA)  and the 
mixture was held at 0°C for 15 min. The precipitate was collected on a 25 mm Millipore filter 
(Millipore Corp., Bedford, Mass.)  (0.2 #m), washed two times with 5 ml of 5% TCA and one 
time with 5  ml of  1 N  HC1.  The filters were dried  1 h  at 80°C  and counted in a Packard 
Gamma Scintillation Spectrometer (Packard Instrument Co., Inc., Downers Grove, ILL). 
Determination  of Protein  and  RNA Synthesis.--Tritiated  uridine (1 mCi/ml, 20 mCi/mg) 
and [14C]L-amino acids (0.1  mCi/ml containing ala, asp, arg, glu, gly, his, ile,  leu, lys, phe, 
pro, set, thr, tyr, and val) were obtained from New England Nuclear. Spleen cells were sus- 
pended in HBSS to 1.5  X  107 cells/ml. Poly A:U was added to half the cells to a  final con- 
centration of 100 ng/ml. Both poly A:U-treated and untreated (control) cells were incubated 
at 37°C  for 10 min, centrifuged, and resuspended to  1.5  X  107 cells/ml in Eagle's MEM. To 
each 2 ml culture was added 2 #Ci [14C]L-amino acid mixture and 10 #Ci [SH]uridine. The cells 
were incubated at 37°C.  At regular intervals, 0.2 ml samples were withdrawn, frozen in dry 
ice-ethanol, and held at -- 70°C until all samples had been collected. The samples were thawed 
and dispersed in 2.0 ml 5% TCA for 15 min at 0°C. The precipitate was collected on a 25 mm 
Millipore filter (0.2 #m), washed two times with 5 ml of 5% TCA and one time with 5 ml of 
1 N  HC1. The filters were dried for 1 h at 80°C,  dispersed in 5 ml of toluene-Omnifluor (New 
England Nuclear)  and counted in a  Packard Tri-Carb liquid scintillation counter  (Packard 
Instrument Co.). 
RESULTS 
Approximately ~  of the nucleated ceils in mouse spleen carry immunoglobulin 
determinants  on  their surface membrane  as indicated by the observation  that 
>40%  become  labeled  when  exposed  to  FITC-RAMIg  serum  (Table  I). 
However,  if, before exposure to the FITC-RAMIg  serum,  the spleen cells were 878  RECEPTOR-DEPLETED  LY~PHOCYTES 
incubated for 30 rain at 37°C after a  10 rain exposure to 100 ng/ml poly A: U, 
less than 25 % of the cells could be scored positive for fluorescein label (Table I). 
Concomitant with the apparent loss of surface Ig determinants upon treat- 
ment with poly A: U was a loss of antigen-binding capacity. When spleen cells 
primed with flGZ were exposed to poly A:U, there was a time-dependent de- 
crease in the amount of 3GZ subsequently bound per 106 cells (Fig. 1). After a 
40 rain incubation period, the poly A : U-treated cells bound only 93 pg ~GZ/106 
cells,  which was only 40 % of the 253 pg 13GZ-bound per 106 untreated control 
cells (Fig. 1). 
The depression of antigen-binding capacity was seen only within a  limited 
TABLE  I 
Poly A : U-Mediated Depression  of Numbers of Cells Labeling u~th FI  TC-RA M Ig 
Spleen cell pretreatment  No. of cells positive/no, examined  Fluorescent  positive cells 
% 
HBSS  351/832  42.2 
Poly A:U  169/813  20.8 
Spleen cells from mice primed with 3GZ were incubated 30 rain at 37°C  after a  10 min 
exposure to  100  ng/ml poly A:U, The cells were washed three times before exposure to 
FITC-RAMIg. 
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FIG.  1.  Poly A:U-mediated depression of specific antigen-binding by primed spleen cell 
populations. Spleen cells obtained from mice primed with/3GZ were exposed to  100 ng/ml 
poly A:U for  10 min, centrifuged, resuspended in HBSS  +  5%  FCS, and returned to the 
37°C water bath. Samples were removed before exposure to poly A:U, after the 10 rain ex- 
posure, and at  15  rain intervals thereafter, and assayed for ~GZ-binding capacity. Vertical 
bars represent the 95% confidence limits around the arithmetic average of three samples. 879 
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concentration  range  of  poly  A:U  (Fig.  2).  Maximum  depression  (approxi- 
mately  60%)  of /3GZ-binding  was  observed  when  the  cells  were  exposed  to 
0.01-1.0 #g/ml poly A:U. Concentrations below or above this range were less 
effective (Fig. 2). 
To  determine  if  the  poly A:U-mediated  depression  of antigen-binding  ca- 
pacity of primed spleen cells involved an active metabolic process, two experi- 
mental approaches were followed: the effect of poly A: U  on the incorporation 
of radiolabeled  metabolic precursors into TCA insoluble cell fractions  and the 
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FIc. 2. Concentration  dependency of poly A:U effect on primed spleen cells. Spleen cells 
obtained from mice primed with/3GZ  were exposed to 0.001-10 #g/ml poly A:U for 10 min 
at 37°C, centrifuged, resuspended in HBSS +  5% FCS, and incubated  for 30 min at 37°C. 
The cells were then washed and assayed for/SGZ-binding capacity. Each point represents the 
arithmetic  average of three samples. Vertical bars represent the 95% confidence limits. 
effect of metabolic poisons on  the  poly A:U-mediated  depression  of antigen- 
binding capacity. 
To determine the effect of poly A: U on RNA and protein synthesis by primed 
spleen  cells,  spleen  cells  were exposed  to  100 ng/ml poly A:U for  10 min  at 
37°C,  centrifuged,  and  resuspended  in  Eagle's  MEM  containing  [3H]uridine 
and  [14C]amino  acids.  Aliquots of the  cells were removed at  regular intervals 
over a 4 h period and assayed for TCA-precipitable 14C and 3H. The poly A: U 
treatment  caused  a  significant  increase  in  [3H]uridine  and  [iaC]amino  acid 
incorporation after 2-3 h  incubation  (Fig. 3). 
To determine  the effect of metabolic poisons on the poly A: U  effect, spleen 
cells  primed  with/3GZ  were  incubated  at  37°C  with  0.1  M  azide  or  10-  ~ M 
iodoacetate for 1 h, or with 10  -5 M  puromycin for 2 h,  and  then  treated  with 
poly A: U in the presence of these metabolic poisons. As can be seen in Table II, 880  RECEPTOR-DEPLETED  LYM]?HOCYTES 
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FIG. 3.  Effect of poly A:U on RNA and protein synthesis by primed spleen cells. Spleen 
cells from mice primed with ~GZ were exposed to  100 ng/ml poly A:U for  10 min at 37°C, 
centrifuged, and resuspended in Eagle's MEM  containing [SH]uridine and [14C]amino acids. 
Samples were removed after various intervals at 37°C and assayed for TCA precipitable  SH 
and 14C. Each point represents the arithmetic average of three samples. Vertical bars represent 
the 95% confidence limits. 
TABLE  II 
Effect of Antimetabolites on the  Poly A : U-Mediated Depression of Antigen-Binding  Capacity 
o[ Primed Spleen Cells 
Antimetabolite 
pg ~GZ bound/lO t cells 
Control  cells  Poly A:U-treated cells 
None  322  4-  79  128  4-  42 
0°C, 40 min  291  4-  71  317  4-  87 
0.1 M  azide,  1 h, 37°C  267  4-  91  302  4-  106 
10  -3 M  iodoacetate,  1 h, 37°C  316  4-  80  383  4-  98 
10  -'~ M  puromycin, 2 h, 37°C  241  4-  83  96  4-  29 
Spleen cells from mice primed with ~GZ were incubated with an antimetabolite  before, 
during, and after exposure to poly A:U. They were then tested for their ability to bind ~GZ. 
It can be seen that the poly A:U effect took place only on cells whose metabolism was not 
arrested by cooling, by azide, or by iodoaeetate.  Puromycin did not prevent the loss of anti- 
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treatment of the cells with poly A: U at 0°C or in the presence of iodoacetate or 
azide at 37°C did not result in a reduction of antigen-binding capacity of  the 
cells, whereas treatment of the cells with poly A:U at 37°C in the absence  of 
these poisons or with puromycin caused a 60 % decrease in  antigen-binding. 
Due to the increased metabolic activity of the poly A: U-treated cells and the 
sensitivity of the suppressive effect to  respiratory poisons,  it  was  considered 
possible that the decreased levels of flGZ bound to the cells might be due  to an 
increased rate of endocytosis of the receptor-antigen complex during  the  short 
37°C incubation required for assay of the enzyme. To exclude this  possibility, 
poly A:U-treated spleen cells were fixed with glutaraldehyde  before exposure 
to flGZ. Glutaraldehyde fixation did not affect the level of flGZ bound by con- 
trol cells, nor did it affect the level of flGZ bound by the poly A: U-treated cells, 
which remained at levels less than 40 % of the control cells (Table III). 
To investigate the hypothesis that  the poly A:U treatment  resulted  in  an 
TABLE III 
Effect of Glutaraldehyde Fixation on ~GZ-Binding by Poly A : U-Treated Spleen Cells 
pg flGZ bound/lO 6 cells 
Spleen ce]l pretreatment 
Nonfixed  Fixed 
HBSS control  318  4-  81  356  =1=  77 
Poly A:U-treated  112  4-  49  131  -4- 38 
Spleen cells from mice primed with 3GZ were treated with poly A:U, washed, and divided 
into two groups: one was treated with 1% glutaraldehyde for 15 min at 4°C (fixed), the other 
was held at 0°C without treatment  (non~xed). The cells were washed and assayed for/3GZ- 
binding capacity. 4- values represent the 95% confidence limits. 
"elution" of receptors for antigen from the membrane, the membrane proteins 
of spleen cells were labeled with a25I by the technique of Marchalonis et al.  (11). 
The cells were exposed to 100 ng/ml poly A: U for 10 rain at 37°C,  centrifuged, 
resuspended in Eagle's MEM, and incubated at 37°C. At regular intervals over 
a  3  h  period,  aliquots were removed and  the  supernatants  assayed  for TCA 
precipitable 125I. As can be seen in Fig. 4, poly A: U treatment of the spleen cells 
resulted in an increased  (>  two times)  rate of release of membrane  proteins 
from the cells within the first hours of incubation. 
As has been reported  by others regarding  the immunoenhancing effects of 
poly A: U  (12), the "stripping" effect of poly A: U seems to involve the adenyl 
cyclase system. Thus,  treatment of spleen cells with dibutyryl cAMP reduced 
the levels of/3GZ-binding to the same extent (60 %) as did treatment with poly 
A:U (Table IV). Theophylline reduced binding only to a  small degree (28%) 
but acted synergistically with suboptimal concentrations of poly A:U (Table 
IV). 
Finally,  to  gain  some  insight  into  the  cell  targets  of poly A:U,  four  cell 882  RECEPTOR-DEPLETED  LYM~PHOCYTES 
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Fro. 4.  Effect of poly A:U on the release of 125I-labeled  membrane proteins. Membrane 
proteins of spleen cells from mice primed with/3GZ were labeled with 12~I. The cells were then 
exposed to 100 ng/ml poly A:U for 10 min at 37°C, centrifuged, and resuspended in Eagle's 
MEM.  Samples were removed at regular intervals and the supernatants assayed for TeA 
precipitable 125I. Each point represents the arithmetic average of three 0.5 ml samples. Ver- 
tical bars represent the 95% confidence limits. 
TABLE IV 
l~ffect of Dibutyryl cA MP and Theophylline  on the Antigen-Bindlng Capacity of Primed Spleen 
Cells 
Cell pretreatment  pg ~GZ bound/106  cells  Depression 
% 
None  306  4-  61  -- 
Poly A:U, 100 ng/ml  134  4- 46  56 
Dibutyryl cAMP, 1 ng/ml  116  4-  39  62 
Theophylline, 1 ng/ml  219  4-  44  28 
Poly A:U, 10 ng/ml, --~ theophylline, 1 ng/ml  107  4-  31  65 
Spleen cells from mice primed with ~GZ were incubated for 10 rain at 37°C with the in- 
dicated reagent. The suspensions were then centrifuged and resuspended in HBSS +  FCS 
containing, in the case of cAMP or theophylline treatment, 1 ng/ml of the respective reagent. 
The  suspensions were incubated  30  rain  at  37°C, washed, and assayed for ~GZ-binding 
capacity.  4- values represent the 95% confidence limits. 
populations were prepared: thymus cells, spleen cells, nonadherent (glass wool- 
absorbed) spleen cells, and cortisone-treated spleen cells. Each cell population 
was treated with poly A:U and then assayed for j3GZ binding capacity. The 
polynucleotide treatment reduced binding in thymocyte populations by 75 %, 
in intact spleen cell populations by 47 %, in nonadherent spleen cell populations 
by 60%, and in cortisone-treated nonadherent spleen cells by 59% (Table V). ROBERT  D.  STOUT'AND  ALBERT  H.  COONS  883 
TABLE  V 
Poly A :U-Mediated  Depression of Specific Antigen-Binding  by Normal  Thymus  and Primed 
Spleen Cells 
Cell population 
pg/$GZ bound/lO 6 cells 
Control cells  Poly A:U treated cells 
Spleen cells 
Nonadherent spleen cells 
Cortisone-treated nonadherent spleen cells 
Thymus cells 
418  -4-  83  223  4-  72 
367  4-  69  145  4-  47 
196  4-  74  80  -4-  31 
92  ±  19  21  ±  6 
Spleen cells were obtained from mice primed with flGZ and were prepared as described in 
Materials  and  Methods.  Thymus cells  were  obtained  from  normal  (not  primed)  6-wk  old 
mice. The cells were incubated 30 min at 37°C after a  10 min exposure to poly A:U, washed 
and assayed for flGZ-binding capacity.  4-  values represent  the 95%  confidence limits. 
DISCUSSION 
The  data  presented  in  this  paper  demonstrate  that  the  antigen-binding 
capacity of both thymus and spleen lymphocytes can be significantly reduced 
by  incubating  the  cells  with  synthetic  polynucleotides.  This  reduction  in 
antigen-binding is not due to a  steric interference of antigen-binding by the 
polynucleotides since:  (a)  the  effect is not  seen  with  concentrations of poly 
A: U in excess of 1 #g/ml; (b) the effect is not seen if the cells are treated with 
poly A: U at 0°C or in the presence of metabolic poisons; and (c) a similar effect 
is obtained with dibutyryl cAMP. 
Evidence  that  labeled  globulin  recovered  from  whole  cells  which  were 
iodinated (125I) by the lactoperoxidase reaction was actually on the cell-surface 
has been reported by Marchalonis et al. (11); using autoradiography and elec- 
tron  microscopy  they  found  the  label  associated  with  the  cell-membrane. 
Vitetta  et al.  (13),  after labeling whole cells,  and  then disintegrating  them, 
found the activity associated only with the membrane fraction. We have not 
looked for the 125I in the experiments reported here; but, as noted in the Results, 
"},-globulin was identified on the surface by immunofluorescence. 
It is therefore suggested that the incubation of the cells with polynucleotides 
results  in  a  loss  of the  receptors for antigen  from  the  cell membrane.  The 
mechanism by which polynucleotides remove the receptors from the membrane 
is not entirely understood at this time. However, it has been demonstrated that 
the immunoglobulin receptors for antigen on both thymocytes (14) and spleen 
cells (14,  15) are constantly turning over on the cell membrane. Treatment of 
the cells with  the polynucleotides accelerates this  turnover within  a  30 rain 
period,  a  time in  which  the polynucleotide stimulation  of RNA  and protein 
synthesis has not yet become apparent (cf. Figs. 3 and 4). The loss of immuno- 
globulin receptors may therefore be the result of accelerated membrane turn- 
over in the absence of comparable increases in protein synthesis--i.e., the ira- 884  RECEPTOR-DEPLETED  LYMPHOCYTES 
munoglobulin may be released from the cell membrane faster than it can be 
replaced. The only other evidence for this hypothesis at this time is that respi- 
ratory poisons,  which have been shown to inhibit the turnover of nlenlbrane 
immunoglobulin (14), prevent the loss of immunoglobulin from polynucleotide- 
treated cells (Table II). 
The physiological significance of receptor depletion is presently under study. 
Such  depletion has  been  observed  after  treatment of  the  cells  with  anti-Ig 
reagents at 37°C (16, 17). The time-course of depletion and subsequent recovery 
of membrane immunoglobulin after treatment with anti-Ig serum  (16, 17)  is 
remarkably similar to that reported for the reduction and subsequent recovery 
of rosette formation by spleen cells treated with polynucleotides (8,  18). The 
depletion of receptors by polynucleotide treatment has been shown to result in 
impaired  antibody responses  after  adoptive  transfer  of  the  treated  cells  to 
irradiated recipients  (8).  Such impairment is probably due to the decreased 
antigen-binding capacity of the receptor depleted cells. 
The binding of antigen by cell populations from the spleen and lymph nodes 
of normal mice has been described and reviewed by Sulitzeanu (1), from normal 
mouse thymus and bone marrow by Sercarz et al. (19), and from normal thymus 
by Modabber et al. (20). The significance of such cells is not clear, although it is 
unlikely that it is due to antibody resulting from antigenic stimulation from 
Escherichia  coli in  the  intestine  because  their  numbers  are  comparable  in 
neonatal, germfree, and adult mice3 
SUMMARY 
The effect of polyadenylic: polyuridylic acid complexes (poly A:U)  on the 
amount of antibody on the surface of various populations of mouse lymphoid 
cells has been investigated by means of a sensitive measure of such activity-- 
the binding by primed cell populations of ~-galactosidase (J3GZ) as an antigen. 
The sensitivity derives from the liberation of fluorescein from an artificial sub- 
strate,  fluorescein-di-/~-galactopyranoside  (FD/~G).  After  incubation  with 
100  ng/ml of poly A:U,  only 40%  of the cells  previously showing antigen- 
binding were still active. The optimum range of activity lay between  0.01- 
1.0 #g/ml poly A: U. Such cells showed increased RNA and protein  synthesis 
as  indicated  by  [3H]uridine  and  [14C]amino acid  incorporation.  The  poly- 
nucleotide effect was abolished by incubation of the cells with sodium azide or 
iodoacetate, but not by puromycin. When the proteins on the cell surface were 
labeled by 125I, poly A: U caused their release into the medium. 
Reports by others that the enhancing effect of polynucleotides on the im- 
mune response involves the adenylcyclase system are consistent with the finding 
reported here that reduction of binding by dibutryl 5t-cyclic monophosphoric 
2 Swain, S. Personal communication. ROBERT  D.  STOUT  AND  ALBERT  H.  COONS  885 
acid (cAMP) and poly A: U were parallel in extent, and that theophylline and 
poly A:U acted synergistically in suboptimal concentrations of each. 
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